Erratum to Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history (Breast Cancer Res Treat, (2014), 144, (635-642), 10.1007/s10549-014-2894-x);Recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 635-642

  Kang, Peter Choon Eng ^a   Phuah, Sze Yee ^a   Sivanandan, Kavitta ^a   Kang, In Nee ^a   Thirthagiri, Eswary ^a   Liu, Jian Jun ^b   Hassan, Norhashimah ^a,c   Yoon, Sook Yee ^a   Thong, Meow Keong ^c   Hui, Miao ^d   Hartman, Mikael ^d,e   Yip, Cheng Har ^c,f   Mohd Taib, Nur Aishah ^c   Teo, Soo Hwang ^a,c  

^a CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Sime Darby Medical Centre Subang Jaya   (Malaysia)

Author keywords

Asia; BRCA1; Breast cancer; Recurrent

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; ASIAN; BINDING SITE; BREAST CANCER; CANCER PATIENT; CANCER RECURRENCE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOSPITALIZATION; HUMAN; INDIAN; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALAYS; MALAYSIAN; MICROSATELLITE MARKER; ONCOGENE; ONCOGENE BRCA2; PREVALENCE; PRIORITY JOURNAL; RAPID TEST; SINGAPOREAN; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; COHORT STUDIES; ETHNIC GROUPS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC TESTING; GENOTYPING TECHNIQUES; HAPLOTYPES; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HETEROZYGOTE; HUMANS; MALAYSIA; MIDDLE AGED; MUTATION; PREVALENCE; SINGAPORE; YOUNG ADULT;

EID: 84899479213     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-015-3360-0     Document Type: Erratum

References (29)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117-1130 (Pubitemid 36530000)
2. Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329-1333 (Pubitemid 46706879)
3. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, and Fu R (2013) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. preventive services task force recommendation. Ann Intern Med. doi:10.7326/M13-1684
4. Daly MB, Axilbund JE, Buys S, Crawford B, Farrell CD, Friedman S, Garber JE, Goorha S, Gruber SB, Hampel H, Kaklamani V, Kohlmann W, Kurian A, Litton J, Marcom PK, Nussbaum R, Offit K, Pal T, Pasche B, Pilarski R, Reiser G, Shannon KM, Smith JR, Swisher E, Weitzel JN, National Comprehensive Cancer, N (2010) Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8(5):562-594
5. Kurian AW, Gong GD, Chun NM, Mills MA, Staton AD, Kingham KE, Crawford BB, Lee R, Chan S, Donlon SS, Ridge Y, Panabaker K, West DW, Whittemore AS, Ford JM (2008) Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 26(29):4752-4758
6. Thirthagiri E, Lee SY, Kang P, Lee DS, Toh GT, Selamat S, Yoon SY, Taib NA, Thong MK, Yip CH, Teo SH (2008) Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res 10(4):R59
7. Tutt A, Robson M, Garber JE, Domchek SM, Audeh MW, Weitzel JN, Friedlander M, Arun B, Loman N, Schmutzler RK, Wardley A, Mitchell G, Earl H, Wickens M, Carmichael J (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 376(9737):235-244
8. Janavicius R (2010) Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control. EPMA J 1(3):397-412
9. Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2(11):1179-1183 (Pubitemid 26375392)
10. Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aube J, Hanna D, Narod SA (2002) A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat 20(5):352-357 (Pubitemid 35285054)
11. Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De Greve J (2008) Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet 9:83
12. van Der Looij M, Wysocka B, Brozek I, Jassem J, Limon J, Olah E (2000) Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland. Hum Mutat 15(5):480-481
13. Gorski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, Mackiewicz A, Stawicka M, Bebenek M, Sorokin D, Fiszer-Maliszewska L, Haus O, Janiszewska H, Niepsuj S, Gozdz S, Zaremba L, Posmyk M, Pluzanska M, Kilar E, Czudowska D, Wasko B, Miturski R, Kowalczyk JR, Urbanski K, Szwiec M, Koc J, Debniak B, Rozmiarek A, Debniak T, Cybulski C, Kowalska E, Toloczko-Grabarek A, Zajaczek S, Menkiszak J, Medrek K, Masojc B, Mierzejewski M, Narod SA, Lubinski J (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110(5):683-686 (Pubitemid 38746026)
14. Bergman A, Einbeigi Z, Olofsson U, Taib Z, Wallgren A, Karlsson P, Wahlstrom J, Martinsson T, Nordling M (2001) The western Swedish BRCA1 founder mutation 3171ins5; a 3.7 cM conserved haplotype of today is a reminiscence of a 1500-year-old mutation. Eur J Hum Genet 9(10):787-793 (Pubitemid 33014592)
15. Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, Herzog J, McGuire C, Neuhausen S (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomark Prev 14(7):1666-1671 (Pubitemid 40995077)
16. TorresD,RashidMU,Gil F,UmanaA,RamelliG,Robledo JF, Tawil M, Torregrosa L, Briceno I, Hamann U (2007) High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. Breast Cancer Res Treat 103(2):225-232 (Pubitemid 46789144)
17. Malaysia, D.o.S. (2013) Statistics yearbook Malaysia 2012. Department of Statistics, Malaysia
18. S.D.o. Statistics (ed) (2013) Yearbook of statistics Singapore 2013. Singapore Department of Statistics, Singapore
19. Kang P, Mariapun S, Phuah SY, Lim LS, Liu J, Yoon SY, Thong MK, Mohd Taib NA, Yip CH, Teo SH (2010) Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families. Breast Cancer Res Treat 124(2):579-584
20. Phuah SY, Lee SY, Kang P, Kang IN, Yoon SY, Thong MK, Hartman M, Sng JH, Yip CH, Taib NA, Teo SH (2013) Prevalence of PALB2 mutations in breast cancer patients in multi-ethnic Asian population in Malaysia and Singapore. PLoS ONE 8(8):e73638
21. Kwong A, Wong LP, Wong HN, Law FB, Ng EK, Tang YH, Chan WK, Ho LS, Kwan KH, Poon M, Wong TT, Leung FC, Chan SW, Ying MW, Ma ES, Ford JM (2009) A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. Breast Cancer Res Treat 117(3):683-686
22. Sng JH, Ali AB, Lee SC, Zahar D, Wong JE, Blake V, Sharif A, Cross G, Iau PT (2003) BRCA1 c.2845insA is a recurring mutation with a founder effect in Singapore Malay women with early onset breast/ovarian cancer. J Med Genet 40(10):e117
23. Balraj P, Khoo AS, Volpi L, Tan JA, Nair S, Abdullah H (2002) Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients. Singapore Med J 43(4):194-197
24. Tang NL, Pang CP, Yeo W, Choy KW, Lam PK, Suen M, Law LK, King WW, Johnson P, Hjelm M (1999) Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst 91(10):882-885 (Pubitemid 29252305)
25. Hu Z, Li WF, Liu XY, Zhang B, Cao MZ, Wang YS, Zhao L, Song CG, Lu JS, Wu J, Di GH, Shen KW, Han QX, Shen ZZ, Huang W, Shao ZM (2007) 5589del8: the recurrent mutation of BRCA1 gene in Chinese breast cancer patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24(4):378-381 (Pubitemid 47292169)
26. Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110(1):99-109 (Pubitemid 351793864)
27. Kwong A, Ng EK, Wong CL, Law FB, Au T, Wong HN, Kurian AW, West DW, Ford JM, Ma ES (2012) Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. PLoS ONE 7(9):e43994
28. Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Goldgar DE, Szabo CI (2006) Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet 7:75
29. Laitman Y, Feng BJ, Zamir IM, Weitzel JN, Duncan P, Port D, Thirthagiri E, Teo SH, Evans G, Latif A, Newman WG, Gershoni-Baruch R, Zidan J, Shimon-Paluch S, Goldgar D, Friedman E (2013) Haplotype analysis of the 185delAG BRCA1 mutation in ethnically diverse populations. Eur J Hum Genet 21(2):212-216